Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases. C. Moermans (Liege, Belgium), K. Damas (Liege, Belgium), J. Guiot (Liege, Belgium), F. Schleich (Liege, Belgium), J. Corhay (Liege, Belgium), M. Henket (Liege, Belgium), R. Louis (Liege, Belgium)
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Disease area: Airway diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Moermans (Liege, Belgium), K. Damas (Liege, Belgium), J. Guiot (Liege, Belgium), F. Schleich (Liege, Belgium), J. Corhay (Liege, Belgium), M. Henket (Liege, Belgium), R. Louis (Liege, Belgium). Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases.. 3339
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis Source: Eur Respir J 2003 Oct 01;22(4):602-608 Year: 2003
Concentration of IL-2, IL-4, IL-8 and TNF in blood serum and sputum in bronchial asthma and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
The levels of proinflammatory cytokines in patients with dust-induced lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 536s Year: 2001
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
Sputum cytokine profiling according to the type of airway inflammation in obstructive pulmonary diseases Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002
Release of IL-1b, IL-6 and TNF-a after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Epithelial derived cytokines IL-25, IL-33 and TSLP in obstructive lung diseases Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
Variability of sputum inflammatory mediators in COPD and ?1-antitrypsin deficiency}, Source: Eur Respir J 2012; 40: 561-569 Year: 2012
Polymorphisms of IL-4, IL-10, and TNF-α gene in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005
Blood cytokine expression in patients with chronic obstructive airway diseases (COAD) Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017